Showing 701-710 of 7756 results for "".
Toxin Time: What’s New and Exciting with Neuromodulators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/toxin-time-whats-new-and-exciting-with-neuromodulators/19768/Joel Cohen, MD takes a deep dive into the most recent data on neuromodulators including post-hoc analyses on the potential durability of response. Dr. Cohen also shares updates on Revance’s DAXI, Botox Cosmetic and liquid toxins under development by Galderma and Allergan.Advances in Treating Pediatric Inflammatory Skin Diseases
https://practicaldermatology.com/topics/pediatric/advances-in-treating-pediatric-inflammatory-skin-diseases/19739/From new treatment guidelines to emerging biologic therapies for psoriasis in pediatric patients, Lawrence Eichenfield, MD says there’s new hope in successfully treating this patient population. He also discusses advances in treating pediatric atopic dermatitis.Advancing Treatment Parameters in Skin of Color with PicoWay
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advancing-treatment-parameters-in-skin-of-color-with-picoway/19623/Join William Kwan, MD for an overview of advanced treatment guidelines for addressing benign Pigmented Lesions with the PicoWay system. Learn how this picosecond laser has minimized risk relative to Q-switched lasers in the treatment of CALMs, lentigines, and more. New case studies from India and TaKeeping Tech in Check
https://practicaldermatology.com/topics/practice-management/keeping-tech-in-check/18427/Dermatologist and their patients can benefit from advances in technology, but the key is that new tools and data are used properly. Neal Bhatia, MD asks Mark Kaufmann, MD how dermatologists can advocate for their specialty and what initiatives are underway.TECHtonic Shifts: Big Data, AI, and Dermatology
https://practicaldermatology.com/topics/practice-management/techtonic-shifts-big-data-ai-and-dermatology/18428/Robots can diagnose skin malignancies. Big data may give insurers ammunition to reduce payments. And dermatologists are left dealing with the fall-out from the rapid evolution of technology. In this special edition of Derm Insider Mark Kaufmann, MD dives into the challenges facing the specialty andTime to Revamp Your Practice Website
https://practicaldermatology.com/topics/practice-management/time-to-revamp-your-practice-website/18706/Your website is your digital storefront. To optimize the benefit of your site, you must review it frequently to be sure you are making the most of technological advancements and search rankings. Keep an eye toward an outstanding user experience (UX). Learn what you need to know to keep your websiteWhat is the best thing you've done to improve your practice in the last year?
https://practicaldermatology.com/topics/practice-management/what-is-the-best-thing-you-ve-done-to-improve-your-practice-in-the-last-year--erovilek/18586/The best thing I did to improve my practice was... PD Asks Joel L. Gelfand, MD what he's done to improve his practice over the last year. Dr. Gelfand says asking patients two simple questions—how much their disease bothers them physically and emotionally—has improved his treatment decision making.Thoughts on Superpotent Topical Corticosteroids in Children
https://practicaldermatology.com/topics/psoriasis/thoughts-on-superpotent-topical-corticosteroids-in-children/18684/"I think we've been overtrained that atrophy occurs all the time," says Neil J. Korman, MD. Caution is essential, but super potent topical corticosteroids can be used safely and effectively for pediatric psoriasis patients, he says. Jerry Bagel, MD agrees, in this bonus video from the Clinical ConveTaltz Approved, Venus Versa Cleared, Sunbathing Linked to Longevity
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-taltz-approved-venus-versa-cleared-sunbathing-linked-to-longevity/18788/The IL-17 inhibitor Taltz (ixekizumab) from Eli Lilly is approved for adults with plaque psoriasis. Venus Concepts' Venus Versa is cleared for multiple aesthetic indications. Strata Sciences gets FDA clearance for new "Classifier Code" for use with MelaFind. Vitals.com shows that wait times are goinAn Off-Label Adjuvant Treatment for Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermtube-journal-club-alam-part-2/18642/In part two of DermTube Journal Club Host Dr. Joshua Zeichner's interview with Murad Alam, MD, they talk about the role of imiquimod as an adjuvant therapy in treating melanoma. Dr. Alam describes how he uses imiquimod off-label after removing melanoma to help prevent recurrence. He also shares how